Compare RPID & OCCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RPID | OCCI |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.8M | 73.0M |
| IPO Year | 2021 | 2017 |
| Metric | RPID | OCCI |
|---|---|---|
| Price | $1.66 | $2.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 222.2K | 207.2K |
| Earning Date | 05-08-2026 | 12-11-2023 |
| Dividend Yield | N/A | ★ 24.32% |
| EPS Growth | ★ 2.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $33,587,000.00 | N/A |
| Revenue This Year | $19.12 | N/A |
| Revenue Next Year | $18.42 | $10.19 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.74 | N/A |
| 52 Week Low | $1.52 | $2.15 |
| 52 Week High | $4.94 | $6.14 |
| Indicator | RPID | OCCI |
|---|---|---|
| Relative Strength Index (RSI) | 38.58 | 52.95 |
| Support Level | N/A | $2.44 |
| Resistance Level | $2.18 | $2.67 |
| Average True Range (ATR) | 0.14 | 0.08 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 20.59 | 58.70 |
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.